A comparative single-cell multi-omic atlas links intrinsic regulatory programs to microenvironmental signaling in pediatric brain tumors

1. Price, M. et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017-2021. Neuro Oncol 26, vi1-vi85 (2024).

2. Louis, D.N. et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23, 1231-1251 (2021).

3. Damodharan, S. & Puccetti, D. Pediatric Central Nervous System Tumor Overview and Emerging Treatment Considerations. Brain Sci 13(2023).

4. Mackay, A. et al. Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. Cancer Cell 32, 520-537.e5 (2017).

5. Ramaswamy, V. et al. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathol 131, 821-31 (2016).

6. Monje, M. et al. Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047). Neuro Oncol 25, 2262-2272 (2023).

7. Stavinoha, P.L., Askins, M.A., Powell, S.K., Pillay Smiley, N. & Robert, R.S. Neurocognitive and Psychosocial Outcomes in Pediatric Brain Tumor Survivors. Bioengineering (Basel) 5(2018).

8. Sleurs, C., Fletcher, P., Mallucci, C., Avula, S. & Ajithkumar, T. Neurocognitive Dysfunction After Treatment for Pediatric Brain Tumors: Subtype-Specific Findings and Proposal for Brain Network-Informed Evaluations. Neurosci Bull 39, 1873-1886 (2023).

9. Gojo, J. et al. Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma. Cancer Cell 38, 44-59 e9 (2020).

10. Neftel, C. et al. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell 178, 835-849 e21 (2019).

11. Hovestadt, V. et al. Resolving medulloblastoma cellular architecture by single-cell genomics. Nature 572, 74-79 (2019).

12. Luo, Z.L. & Lu, R. Human Fetal Cerebellar Cell Atlas Informs Medulloblastoma Origin and Oncogenesis. Neuro-Oncology 25(2023).

13. Smith, K.S. et al. Unified rhombic lip origins of group 3 and group 4 medulloblastoma. Nature 609, 1012-1020 (2022).

14. Liu, I. et al. The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location. Nat Genet 54, 1881-1894 (2022).

15. Gillen, A.E. et al. Single-Cell RNA Sequencing of Childhood Ependymoma Reveals Neoplastic Cell Subpopulations That Impact Molecular Classification and Etiology. Cell Rep 32, 108023 (2020).

16. Vladoiu, M.C. et al. Childhood cerebellar tumours mirror conserved fetal transcriptional programs. Nature 572, 67-73 (2019).

17. Jessa, S. et al. Stalled developmental programs at the root of pediatric brain tumors. Nature Genetics 51, 1702-1713 (2019).

18. Jessa, S. et al. K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas. Nat Genet 54, 1865-1880 (2022).

19. Northcott, P.A. et al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature 511, 428-34 (2014).

20. Mack, S.C. et al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature 506, 445-50 (2014).

21. Schwartzentruber, J. et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226-31 (2012).

22. Lewis, P.W. et al. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340, 857-61 (2013).

23. Jones, D.T.W. et al. Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours. Nat Rev Cancer 19, 420-438 (2019).

24. Gröbner, S.N. et al. The landscape of genomic alterations across childhood cancers. Nature 555, 321-327 (2018).

25. Jones, C. et al. Pediatric high-grade glioma: biologically and clinically in need of new thinking. Neuro Oncol 19, 153-161 (2017).

26. Filbin, M. & Monje, M. Developmental origins and emerging therapeutic opportunities for childhood cancer. Nat Med 25, 367-376 (2019).

27. Zhao, S., Allis, C.D. & Wang, G.G. The language of chromatin modification in human cancers. Nature Reviews Cancer 21, 413-430 (2021).

28. Timp, W. & Feinberg, A.P. Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat Rev Cancer 13, 497-510 (2013).

29. Hanahan, D. Hallmarks of Cancer: New Dimensions. Cancer Discov 12, 31-46 (2022).

30. Tirosh, I. & Suva, M.L. Cancer cell states: Lessons from ten years of single-cell RNA-sequencing of human tumors. Cancer Cell 42, 1497-1506 (2024).

31. Grabovska, Y. et al. Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity. Nature Communications 11, 4324 (2020).

32. DeCordova, S. et al. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma. Front Immunol 11, 1402 (2020).

33. Jin, S., Plikus, M.V. & Nie, Q. CellChat for systematic analysis of cell–cell communication from single-cell transcriptomics. Nature Protocols 20, 180-219 (2025).

34. Troulé, K. et al. CellPhoneDB v5: inferring cell–cell communication from single-cell multiomics data. Nature Protocols 20, 3412-3440 (2025).

35. Browaeys, R., Saelens, W. & Saeys, Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nature Methods 17, 159-162 (2020).

36. Ma, S. et al. Chromatin Potential Identified by Shared Single-Cell Profiling of RNA and Chromatin. Cell 183, 1103-1116.e20 (2020).

37. Chen, X., Yang, W., Roberts, C.W.M. & Zhang, J. Developmental origins shape the paediatric cancer genome. Nat Rev Cancer 24, 382-398 (2024).

38. Suvà, M.L. & Tirosh, I. The Glioma Stem Cell Model in the Era of Single-Cell Genomics. Cancer Cell 37, 630-636 (2020).

39. Neftel, C. et al. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell 178, 835-849.e21 (2019).

40. Tang, L. et al. Joint analysis of chromatin accessibility and gene expression in the same single cells reveals cancer-specific regulatory programs. Cell Syst 16, 101266 (2025).

41. Liu, L. et al. Deconvolution of single-cell multi-omics layers reveals regulatory heterogeneity. Nature Communications 10, 470 (2019).

42. Cao, J. et al. Joint profiling of chromatin accessibility and gene expression in thousands of single cells. Science 361, 1380-1385 (2018).

43. Zhu, C. et al. An ultra high-throughput method for single-cell joint analysis of open chromatin and transcriptome. Nature Structural & Molecular Biology 26, 1063-1070 (2019).

44. Chen, S., Lake, B.B. & Zhang, K. High-throughput sequencing of the transcriptome and chromatin accessibility in the same cell. Nature Biotechnology 37, 1452-1457 (2019).

45. Xu, W. et al. ISSAAC-seq enables sensitive and flexible multimodal profiling of chromatin accessibility and gene expression in single cells. Nat Methods 19, 1243-1249 (2022).

46. Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573-3587.e29 (2021).

47. Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods 16, 1289-1296 (2019).

48. Gerdes, J. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol 1, 199-206 (1990).

49. Zhou, T., Niu, Y. & Li, Y. Advances in research on malignant tumors and targeted agents for TOP2A (Review). Mol Med Rep 31(2025).

50. Oehlmann, M., Score, A.J. & Blow, J.J. The role of Cdc6 in ensuring complete genome licensing and S phase checkpoint activation. J Cell Biol 165, 181-90 (2004).

51. Adini, A. et al. The stem cell marker prominin-1/CD133 interacts with vascular endothelial growth factor and potentiates its action. Angiogenesis 16, 405-16 (2013).

52. Filbin, M.G. et al. Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360, 331-335 (2018).

53. Bax, D.A. et al. EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines. Clin Cancer Res 15, 5753-61 (2009).

54. Mondal, G. et al. Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition. Acta Neuropathol 139, 1071-1088 (2020).

55. Boulay, G. et al. OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma. Cancer Discov 7, 288-301 (2017).

56. Cavalli, F.M.G. et al. Intertumoral Heterogeneity within Medulloblastoma Subgroups. Cancer Cell 31, 737-754.e6 (2017).

57. Servidei, T. et al. Cell-of-Origin and Genetic, Epigenetic, and Microenvironmental Factors Contribute to the Intra-Tumoral Heterogeneity of Pediatric Intracranial Ependymoma. Cancers (Basel) 13(2021).

58. Ahmadov, U. et al. A highly abundant circular RNA from the RMST locus plays a role in posterior fossa ependymoma pathogenesis. Brain Pathology 36, e70071 (2026).

59. Feng, J., Liu, T., Qin, B., Zhang, Y. & Liu, X.S. Identifying ChIP-seq enrichment using MACS. Nat Protoc 7, 1728-40 (2012).

60. Stuart, T., Srivastava, A., Madad, S., Lareau, C.A. & Satija, R. Single-cell chromatin state analysis with Signac. Nature Methods 18, 1333-1341 (2021).

61. Heinz, S., Romanoski, C.E., Benner, C. & Glass, C.K. The selection and function of cell type-specific enhancers. Nat Rev Mol Cell Biol 16, 144-54 (2015).

62. Harrow, J. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 22, 1760-74 (2012).

63. Li, Y.E. et al. A comparative atlas of single-cell chromatin accessibility in the human brain. Science 382, eadf7044 (2023).

64. Mannens, C.C.A. et al. Chromatin accessibility during human first-trimester neurodevelopment. Nature 647, 179-186 (2025).

65. Terekhanova, N.V. et al. Epigenetic regulation during cancer transitions across 11 tumour types. Nature 623, 432-441 (2023).

66. Alderton, G.K. Tumorigenesis: the origins of glioma. Nat Rev Cancer 11, 627 (2011).

67. Taylor, M.D. et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8, 323-35 (2005).

68. Kartha, V.K. et al. Functional inference of gene regulation using single-cell multi-omics. Cell Genom 2(2022).

69. Fishilevich, S. et al. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database (Oxford) 2017(2017).

70. Hanashima, C., Shen, L., Li, S.C. & Lai, E. Brain factor-1 controls the proliferation and differentiation of neocortical progenitor cells through independent mechanisms. J Neurosci 22, 6526-36 (2002).

71. Ornitz, D.M. & Itoh, N. The Fibroblast Growth Factor signaling pathway. Wiley Interdiscip Rev Dev Biol 4, 215-66 (2015).

72. Kiss, Z., Mudryj, M. & Ghosh, P.M. Non-circadian aspects of BHLHE40 cellular function in cancer. Genes Cancer 11, 1-19 (2020).

73. Jin, L., Huang, S., Guan, C. & Chang, S. ETS1-activated SNHG10 exerts oncogenic functions in glioma via targeting miR-532-3p/FBXL19 axis. Cancer Cell Int 20, 589 (2020).

74. Liang, J. et al. Ubiquitin-specific protease 22 promotes the proliferation, migration and invasion of glioma cells. Cancer Biomark 23, 381-389 (2018).

75. Lötsch, D. et al. Targeting fibroblast growth factor receptors to combat aggressive ependymoma. Acta Neuropathol 142, 339-360 (2021).

76. Adesina, A.M. et al. FOXG1 expression shows correlation with neuronal differentiation in cerebellar development, aggressive phenotype in medulloblastomas, and survival in a xenograft model of medulloblastoma. Hum Pathol 46, 1859-71 (2015).

77. Lin, C.Y. et al. Active medulloblastoma enhancers reveal subgroup-specific cellular origins. Nature 530, 57-62 (2016).

78. Mack, S.C. et al. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling. Nature 553, 101-105 (2018).

79. Sepp, M. et al. Cellular development and evolution of the mammalian cerebellum. Nature 625, 788-796 (2024).

80. McDonough, A. et al. Unipolar (Dendritic) Brush Cells Are Morphologically Complex and Require Tbr2 for Differentiation and Migration. Front Neurosci 14, 598548 (2020).

81. Tebbe, L. et al. Prph2 disease mutations lead to structural and functional defects in the RPE. Faseb j 36, e22284 (2022).

82. Buenaventura, D.F., Corseri, A. & Emerson, M.M. Identification of Genes With Enriched Expression in Early Developing Mouse Cone Photoreceptors. Invest Ophthalmol Vis Sci 60, 2787-2799 (2019).

83. Li, S., Qiu, F., Xu, A., Price, S.M. & Xiang, M. Barhl1 regulates migration and survival of cerebellar granule cells by controlling expression of the neurotrophin-3 gene. J Neurosci 24, 3104-14 (2004).

84. Katsushima, K. et al. The long noncoding RNA lnc-HLX-2-7 is oncogenic in Group 3 medulloblastomas. Neuro Oncol 23, 572-585 (2021).

85. Roussel, M.F. & Robinson, G.W. Role of MYC in Medulloblastoma. Cold Spring Harb Perspect Med 3(2013).

86. Wang, D. & Owler, B.K. Expression of AQP1 and AQP4 in paediatric brain tumours. J Clin Neurosci 18, 122-7 (2011).

87. Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nature Methods 14, 1083-1086 (2017).

88. Schep, A.N., Wu, B., Buenrostro, J.D. & Greenleaf, W.J. chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data. Nat Methods 14, 975-978 (2017).

89. Owa, T. et al. Meis1 Coordinates Cerebellar Granule Cell Development by Regulating Pax6 Transcription, BMP Signaling and Atoh1 Degradation. J Neurosci 38, 1277-1294 (2018).

90. Ayrault, O. et al. Atoh1 inhibits neuronal differentiation and collaborates with Gli1 to generate medulloblastoma-initiating cells. Cancer Res 70, 5618-27 (2010).

91. Garancher, A. et al. NRL and CRX Define Photoreceptor Identity and Reveal Subgroup-Specific Dependencies in Medulloblastoma. Cancer Cell 33, 435-449.e6 (2018).

92. Joshi, P. et al. Cell-state plasticity drives heterogeneity in Group 3/4 medulloblastoma. (bioRxiv, 2024).

93. Chen, A., Wang, H., Li, X., Anastasaki, C. & Gutmann, D.H. IRX2 and NPTX1 differential regulation of β-catenin underlies MEK-mediated proliferation in human neuroglial cells. Genes Dev 39, 697-705 (2025).

94. Carro, M.S. et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 463, 318-25 (2010).

95. Muzio, L. et al. Emx2 and Pax6 control regionalization of the pre-neuronogenic cortical primordium. Cereb Cortex 12, 129-39 (2002).

96. Mikheeva, S.A. et al. TWIST1 promotes invasion through mesenchymal change in human glioblastoma. Mol Cancer 9, 194 (2010).

97. Shapiro, J.A. et al. OpenPBTA: The Open Pediatric Brain Tumor Atlas. Cell Genom 3, 100340 (2023).

98. Hornig, J. et al. The transcription factors Sox10 and Myrf define an essential regulatory network module in differentiating oligodendrocytes. PLoS Genet 9, e1003907 (2013).

99. Schmidt-Edelkraut, U., Hoffmann, A., Daniel, G. & Spengler, D. Zac1 regulates astroglial differentiation of neural stem cells through Socs3. Stem Cells 31, 1621-32 (2013).

100. Falcone, C., Filippis, C., Granzotto, M. & Mallamaci, A. Emx2 expression levels in NSCs modulate astrogenesis rates by regulating EgfR and Fgf9. Glia 63, 412-22 (2015).

101. Lau, J. et al. STAT3 Blockade Inhibits Radiation-Induced Malignant Progression in Glioma. Cancer Res 75, 4302-11 (2015).

102. Ijaz, H. et al. Pediatric high-grade glioma resources from the Children's Brain Tumor Tissue Consortium. Neuro Oncol 22, 163-165 (2020).

103. Mandal, P., Belapurkar, V., Nair, D. & Ramanan, N. Vinculin-mediated axon growth requires interaction with actin but not talin in mouse neocortical neurons. Cell Mol Life Sci 78, 5807-5826 (2021).

104. Leloup, L. & Wells, A. Calpains as potential anti-cancer targets. Expert Opin Ther Targets 15, 309-23 (2011).

105. Huang, X. et al. CHL1 negatively regulates the proliferation and neuronal differentiation of neural progenitor cells through activation of the ERK1/2 MAPK pathway. Mol Cell Neurosci 46, 296-307 (2011).

106. Byun, H. et al. Rorβ regulates selective axon-target innervation in the mammalian midbrain. Development 146(2019).

107. Geering, B. Death-associated protein kinase 2: Regulator of apoptosis, autophagy and inflammation. Int J Biochem Cell Biol 65, 151-4 (2015).

108. Saberiyan, M. et al. The role of DAPK2 as a key regulatory element in various human cancers: a systematic review. Mol Biol Rep 51, 886 (2024).

109. Muyas, F. et al. De novo detection of somatic mutations in high-throughput single-cell profiling data sets. Nature Biotechnology 42, 758-767 (2024).

110. Zhang, K.Y. et al. ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors. Acta Neuropathol 148, 19 (2024).

111. Wen, K., Zhu, W., Luo, Z. & Wang, W. Machine learning-based identification of histone deacetylase-associated prognostic factors and prognostic modeling for low-grade glioma. Discov Oncol 15, 824 (2024).

112. Efremova, M., Vento-Tormo, M., Teichmann, S.A. & Vento-Tormo, R. CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes. Nature Protocols 15, 1484-1506 (2020).

113. Zhang, Y. et al. CellCall: integrating paired ligand-receptor and transcription factor activities for cell-cell communication. Nucleic Acids Res 49, 8520-8534 (2021).

114. Cheng, J., Zhang, J., Wu, Z. & Sun, X. Inferring microenvironmental regulation of gene expression from single-cell RNA sequencing data using scMLnet with an application to COVID-19. Brief Bioinform 22, 988-1005 (2021).

115. Pitcher, J.L., Alexander, N., Miranda, P.J. & Johns, T.G. ErbB4 in the brain: Focus on high grade glioma. Front Oncol 12, 983514 (2022).

116. Wang, C. et al. miR-124-3p and miR-194-5p regulation of the PI3K/AKT pathway via ROR2 in medulloblastoma progression. Cancer Gene Ther 31, 941-954 (2024).

117. Shiraishi, R. et al. Cancer-specific epigenome identifies oncogenic hijacking by nuclear factor I family proteins for medulloblastoma progression. Developmental Cell 59, 2302-2319.e12 (2024).

118. Masurkar, S.A., Deogharkar, A., Bharambe, H.S. & Shirsat, N.V. Downregulation of CRX, a Group 3-specific oncogenic transcription factor, inhibits TGF-β/activin signaling in medulloblastoma cells. Biochem Biophys Res Commun 568, 76-82 (2021).

119. Sussman, J.H. et al. A longitudinal single-cell and spatial multiomic atlas of pediatric high-grade glioma. Cell Rep Med 7, 102766 (2026).

120. Cheng, S. et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184, 792-809.e23 (2021).

121. Whyte, W.A. et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307-19 (2013).

122. Lovén, J. et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153, 320-34 (2013).

123. Bradner, J.E., Hnisz, D. & Young, R.A. Transcriptional Addiction in Cancer. Cell 168, 629-643 (2017).

124. Barthel, F.P. et al. Systematic analysis of telomere length and somatic alterations in 31 cancer types. Nature Genetics 49, 349-357 (2017).

125. Corces, M.R. et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat Methods 14, 959-962 (2017).

126. Rosenberg, A.B. et al. Single-cell profiling of the developing mouse brain and spinal cord with split-pool barcoding. Science 360, 176-182 (2018).

127. Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17, 10-12 (2011).

128. Hawkins, J.A., Jones, S.K., Jr., Finkelstein, I.J. & Press, W.H. Indel-correcting DNA barcodes for high-throughput sequencing. Proc Natl Acad Sci U S A 115, E6217-e6226 (2018).

129. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15-21 (2013).

130. Wolf, F.A., Angerer, P. & Theis, F.J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol 19, 15 (2018).

131. Granja, J.M. et al. ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis. Nat Genet 53, 403-411 (2021).

132. Bredikhin, D., Kats, I. & Stegle, O. MUON: multimodal omics analysis framework. Genome Biol 23, 42 (2022).

133. Satpathy, A.T. et al. Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion. Nat Biotechnol 37, 925-936 (2019).

134. Gao, R. et al. Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes. Nat Biotechnol 39, 599-608 (2021).

135. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol 9, R137 (2008).

136. Yu, G., Wang, L.G. & He, Q.Y. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382-3 (2015).

137. Zhang, Y., Chen, F., Donehower, L.A., Scheurer, M.E. & Creighton, C.J. A pediatric brain tumor atlas of genes deregulated by somatic genomic rearrangement. Nat Commun 12, 937 (2021).